Back
LeMaitre Vascular Vs. Perspective Therapeutics Industry Stock Comparison
Buy
58
LMAT
LeMaitre Vascular
Last Price:
$92.19
Seasonality Move:
2.06%
Sell
23
CATX
Perspective Therapeutics
Last Price:
$2.87
Seasonality Move:
41.25%
Buy
58
LeMaitre Vascular (LMAT)
is a Buy
Is LeMaitre Vascular a Buy, Sell or Hold?
-
The current LeMaitre Vascular [LMAT] share price is $92.13. The Score for LMAT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
LMAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
-
The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LMAT Stock Price Chart
What is LeMaitre Vascular's stock price today?
-
The LeMaitre Vascular share price today is $92.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LMAT is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $2.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
LMAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.14 | Sell |
Relative Strength Index (14 RSI): | 36.22 | Sell |
Chaikin Money Flow: | 7277 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.68 - 106.5) | Sell |
Bollinger Bands (100): | (85.3 - 99.88) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.39 | Sell |
Relative Strength Index (14 RSI): | 19.38 | Sell |
Chaikin Money Flow: | -1073375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.81 - 5.45) | Sell |
Bollinger Bands (100): | (6.71 - 15.03) | Sell |
LMAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.95 | Sell |
20-day SMA: | 100.43 | Sell |
50-day SMA: | 97.44 | Sell |
200-day SMA: | 83.75 | Buy |
8-day EMA: | 94.34 | Sell |
20-day EMA: | 97.7 | Sell |
50-day EMA: | 97.16 | Sell |
200-day EMA: | 85.16 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.2 | Sell |
20-day SMA: | 3.62 | Sell |
50-day SMA: | 7.97 | Sell |
200-day SMA: | 12.2 | Sell |
8-day EMA: | 3.18 | Sell |
20-day EMA: | 4.2 | Sell |
50-day EMA: | 6.97 | Sell |
200-day EMA: | 10.02 | Sell |
LeMaitre Vascular Earnings Growth & LMAT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.22 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
LeMaitre Vascular Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |